Correspondence 0001493152-24-018239 from RenovoRx, Inc. (RNXT)

RenovoRx, Inc.
Date: May 8, 2024 · CIK: 0001574094 · Accession: 0001493152-24-018239

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-278841

Date

May 8, 2024

Author

Chief

Form

CORRESP

Company

RenovoRx, Inc.

Letter

VIA EDGAR Division of Corporation Finance Office of Life Sciences Attention: Chris Edwards Re: RenovoRx, Inc. Registration Statement on Form S-3 Filed April 19, 2024 File No. 333-278841

Dear Mr. Edwards:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, RenovoRx, Inc. (the “Company”) hereby requests acceleration of effectiveness of the above referenced Registration Statement, as amended, so that it will become effective at 4:30 p.m., Eastern time, on Friday, May 10, 2024 (the “Effective Time”). The Company hereby grants to Lawrence A. Rosenbloom, Esq. of Ellenoff Grossman & Schole LLP the authority to communicate to the staff of the U.S. Securities and Exchange Commission one or more requests for any potential deferral of the Effective Time.

Very
truly yours,
/s/
Shaun R. Bagai

Show Raw Text

CORRESP
1
filename1.htm

RENOVORX,
INC.

4546
El Camino Real, Suite B1

Los
Altos, CA 94022

May
8, 2024

VIA
EDGAR

U.S.
SECURITIES AND EXCHANGE COMMISSION

Division
of Corporation Finance

Office
of Life Sciences

100
F Street, N.E.

Washington,
DC 20549

Attention:
Chris Edwards

    Re:
    RenovoRx,
    Inc.

    Registration
    Statement on Form S-3

    Filed
    April 19, 2024

    File
    No. 333-278841

Dear
Mr. Edwards:

Pursuant
to Rule 461 under the Securities Act of 1933, as amended, RenovoRx, Inc. (the “Company”) hereby requests acceleration
of effectiveness of the above referenced Registration Statement, as amended, so that it will become effective at 4:30 p.m., Eastern time,
on Friday, May 10, 2024 (the “Effective Time”). The Company hereby grants to Lawrence A. Rosenbloom, Esq. of Ellenoff
Grossman & Schole LLP the authority to communicate to the staff of the U.S. Securities and Exchange Commission one or more requests
for any potential deferral of the Effective Time.

    Very
    truly yours,

    /s/
    Shaun R. Bagai

    Shaun
    R. Bagai

    Chief
    Executive Officer

SecProbe.io